Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ponsse Plc - Managers' Transactions, Tiina Kautonen

Ponsse Plc, Managers’ Transactions, 25 October, 2024 at 7:00 p.m (EEST) Ponsse Plc - Managers' Transactions, Tiina Kautonen Ponsse Plc has received the following disclosure: Person subject to the notification requirement Name: Kautonen, Tiina Position: Other senior manager Issuer: Ponsse Plc LEI: 7437000IQJS6ZC1FR041 Notification type: INITIAL NOTIFICATION Reference number: 7437000IQJS6ZC1FR041_20241024142202_38 ____________________________________________ Transaction date: 2024-10-23 Venue not applicable Instrument type: SHARE ISIN: FI0009005078

Ponsse Plc - Managers' Transactions, Juha Inberg

Ponsse Plc, Managers’ Transactions, 25 October, 2024 at 7:00 p.m (EEST)  Ponsse Plc - Managers' Transactions, Juha Inberg Ponsse Plc has received the following disclosure: Person subject to the notification requirement Name: Inberg, Juha Position: Other senior manager Issuer: Ponsse Plc LEI: 7437000IQJS6ZC1FR041   Notification type: INITIAL NOTIFICATION Reference number: 7437000IQJS6ZC1FR041_20241024142202_37 ____________________________________________   Transaction date: 2024-10-23 Venue not applicable Instrument type: SHARE ISIN:

Sinch announces goodwill impairment and preliminary results related to the third quarter 2024

Stockholm, Sweden – 25 October 2024 – Sinch AB (publ), which is pioneering the way the world communicates through its Customer Communications Cloud, announces the outcome of its goodwill impairment test and discloses preliminary results for the third quarter 2024. Goodwill impairmentSinch regularly assesses goodwill and has conducted an impairment test when finalizing results for the third quarter. The impairment test has resulted in a total impairment charge of SEK 6,000 million. The charge is attributable to the product category Applications and primarily relates to MessageMedia,

Notice to Debentureholders

RNS ANNOUNCEMENT Notice to Debentureholders ROYAL BANK OF CANADAU.S.$300,000,000 Floating Rate Debenture Notes Due 2085 (the "Notes")ISIN: GB0007542557 NOTICE IS HEREBY GIVEN that, as previously announced, as a result of all USD LIBOR settings ceasing to be published after September 30, 2024, RBC, as Interest Determination Agent in respect of the Notes, consulted with an independent adviser with appropriate expertise to determine a successor or replacement rate for 3-month USD LIBOR and any applicable adjustment spread and changes necessary for its proper operation. Following

Relais Group Plc: Share Repurchase 25.10.2024

Relais Group Plc  ANNOUNCEMENT  25.10.2024 Relais Group Plc: Share Repurchase 25.10.2024 In the Helsinki Stock Exchange Trade date           25.10.2024Bourse trade         BuyShare                  RELAISAmount             300 SharesAverage price/ share    14,8000 EURTotal cost            4 440,00 EUR Relais Group Plc now holds a total of 69 905 sharesincluding the shares repurchased on 25.10.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B0BDCB21 Issuer Name STRATEGIC EQUITY CAPITAL PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name City of London Investment Management Company Limited City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Full name of shareholder(s) if different from the person(s)

Director/PDMR Shareholding

25 October 2024 Keller Group plc Director/PDMR Shareholding Keller Group plc (the "Company") announces that on 25 October 2024 it was notified of the following transaction in the Company's ordinary shares of 10 pence each (“Shares”) undertaken by a Person Closely Associated (“PCA”) with a Person Discharging Managerial Responsibilities (“PDMR”): Helen Speakman, a PCA with Michael Speakman, PDMR, disposed of 43,000 Shares at GBP 16.32 per Share. The transaction took place on 24 October 2024 in London (XLON). Following this transaction, Mr. Speakman's total interest in Shares

#24-369 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-368 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Medivir's CEO to BioStock: "Fostrox is unique in its kind"

Medivir's phase I study, which established clinical proof-of-concept for fostrox as monotherapy in patients with liver cancer, has been published in the Journal of Hepatocellular Carcinoma. The study shows that fostrox is safe and well-tolerated with preliminary anti-tumour activity, confirming that the drug specifically targets cancer cells in the liver while sparing healthy cells. BioStock reached out to CEO Jens Lindberg for a comment.Read the article at biostock.se: https://www.biostock.se/en/2024/10/medivirs-ceo-fostrox-is-unique-in-its-kind/ This is a press release from BioStock

Helsinki District Court has passed a court decision in a dispute between LähiTapiola Keskustakiinteistöt Ky and Stockmann AS

LINDEX GROUP plc, Inside Information 25.10.2024 at 16:45 EEST   Helsinki District Court has passed a court decision in a dispute between LähiTapiola Keskustakiinteistöt Ky and Stockmann AS   A court decision has today been received by the Helsinki District Court in a dispute between LähiTapiola Keskustakiinteistöt Ky and Stockmann AS concerning the amount of compensation for the termination of the lease of business premises located in Stockmann’s department store in Tapiola in accordance with the restructuring process.   Helsinki District Court has in its court decision

Aker ASA: Presentation of Third-Quarter Results 2024

Aker ASA will publish its financial results for the third quarter of 2024 on Wednesday, November 6, 2024, at 07:00 CET. An online webcast presentation of the results will be available the same day at 09:00 CET.Webcast details: Date: Wednesday, November 6, 2024Time: 09:00am CETFormat: WebcastLanguage: EnglishLink: www.akerasa.com/webcast There will be a prepared Q&A session following the presentation. It is possible to submit questions to fredrik.berge@akerasa.com in advance. The presentation and material will be made available at www.akerasa.com and www.newsweb.no ENDS

Notice to Noteholders

RNS ANNOUNCEMENT Royal Bank of CanadaOctober 25, 2024Notice to Noteeholders ROYAL BANK OF CANADAUSD 20,000,000 Floating Rate Notes due March 2029 (the "Notes")ISIN: XS1971424723 NOTICE IS HEREBY GIVEN that as a result of a Benchmark Event (as defined in the terms and conditions of the Notes (the "Conditions")) having occurred in respect of the Notes in relation to the Original Reference Rate no longer being published after September 30, 2024, Royal Bank of Canada (the "Issuer"), appointed and consulted with Conv-Ex Advisors Limited as Independent Adviser pursuant to the

Freetrailer Group reports summary from the annual general meeting

On Thursday 24 October 2024, at 11.00 am, the Annual General Meeting of Freetrailer Group A/S, CVR no. 28 89 19 38, was held at the company's registered office, Gladsaxe Møllevej 67, 2860 Søborg. Present were shareholders representing 36.51% of the company's total share capital of nominally DKK 7,178,493, divided into 9,571,324 shares of DKK 0.75. The Board of Directors of Freetrailer Group A/S was represented at the Annual General Meeting as well as the company's auditor. The CEO of Freetrailer Group A/S was present. The following agenda was set for the general meeting: 1.

Disclosure as attachment of the Nanoform 2022 Report of the Board of Directors and Financial Statements which were previously linked to a Company Release

Company release Nanoform Finland Plc October 25, 2024 16.15 Finnish time / 15.15 Swedish time Disclosure as attachment of the Nanoform 2022 Report of the Board of Directors and Financial Statements which were previously linked to a Company Release Nanoform Finland Plc reported February 28, 2023, FY2022 results with a Company Release including Financial Statements Review for January-December 2022. In the Company Release the link to all additional documents were provided, including ‘Report of the Board of Directors and Financial Statements’, in English and Finnish. The ‘

Change in the number of shares and votes in Beyond Frames Entertainment AB (publ)

The Swedish Companies Registration Office has registered an increase in the number of shares and share capital in Beyond Frames Entertainment AB (publ), attributable to employee option program (“kvalificerade personaloptioner”) claimed in relation to the Incentive Program 2021/2024, which was communicated on 22 June 2021. A total of 125 000 shares were issued, which means that the number of shares in the company after registration amounts to 17 465 409. The share capital in the Company has increased by SEK 6 250 and amounts to a total of SEK 873 270.

Stora Enso Oyj: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (24 October 2024)

STORA ENSO OYJ STOCK EXCHANGE RELEASE 25 October 2024 at 16:05 EESTStora Enso Oyj received a notification pursuant to chapter 9, section 5 of the Securities Market Act from BlackRock, Inc on 25 October 2024. On 24 October 2024, BlackRock's holding in Stora Enso’s shares increased above the 5 percent threshold. +----------------+--------------+-----------------------------+---------------+|  |% of shares |% of shares and voting rights|Total of both || |and voting |through financial instruments|in % (7.A + || |rights |(

InCoax Networks AB (publ) publishes appointed Nomination Committee

The InCoax Networks AB Nomination Committee should consist of four members with one representative from each of the three largest shareholders as of September 30[th] that wish to nominate a member, and the Chairman of the Board.The Nomination Committee has now been appointed and consists of; Stefan Engström representing Saugatruck Invest AB, Anders Nilsson representing Norrlandspojkarna AB, Lars Berggren representing BLL Invest AB and Peter Agardh in his capacity as Chairman of the Board. The Nomination Committee shall prepare proposals in the following matters to be submitted to the

Credit Loss Provisions Impact Condo’s Q3 Results

Condo Nordic Holding AB announces that its third-quarter financial results will be impacted bya credit loss provision related to the bankruptcy of one of its minor shareholders, Opema Oy.Condo Nordic Holding AB announces that its third-quarter financial results will be impacted bya credit loss provision related to the bankruptcy of one of its minor shareholders, Opema Oy. Although Opema Oy has appealed the bankruptcy ruling to the Supreme Court of Finland,Condo has decided to prudently provision for the full potential credit exposure, totalling EUR 422,000. This proactive measure

Diagonal Bio announces pilot test of LAMPlify® at Norwegian University of Life Sciences

Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces the commencement of a six-month pilot test of its point-of-care diagnostic platform, LAMPlify®, at the Norwegian University of Life Sciences (NMBU) in Ås. The pilot, which will be conducted in collaboration with the Faculty of Veterinary Medicine and Biosciences, specifically the Department of Companion Animal Clinical Sciences, aims to evaluate the effectiveness and potential integration of LAMPlify® within the university's equine hospital.The veterinary team at NMBU, led by Associate Professor Ingunn Risnes Hellings, will

Read original

Elkem ASA – Successful listing of bond issuances

Oslo, 25 October 2024 Reference is made to the stock exchange notice of 5 September 2024 regarding the issuances of senior unsecured bonds. Elkem has prepared a listing prospectus for the admission of the bonds to trading on the Oslo Stock Exchange, scheduled for Monday 28 October 2024. The base prospectus prepared by Elkem ASA was approved by Finanstilsynet (The Financial Supervisory Authority of Norway) on 29 January 2024. Final Terms are available on the company's website: -           ISIN NO0013331280 - NOK 1,000,000,000 senior unsecured bond issue FRN 2024/2027 -

There are no items matching the current filter
There are no more items matching the current filter
Back to top